The Discounted Cash Flow (DCF) valuation of Anika Therapeutics Inc (ANIK) is 6.65 USD. With the latest stock price at 8.66 USD, the upside of Anika Therapeutics Inc based on DCF is -23.2%.
Based on the latest price of 8.66 USD and our DCF valuation, Anika Therapeutics Inc (ANIK) is a sell. selling Anika stocks now will result in a potential gain of 23.2%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.3% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 5.07 - 24.89 | 6.65 |
| Upside | -41.5% - 187.4% | -23.2% |